Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histological”

42,507 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42,507 results

Testing effectiveness (Phase 2)UnknownNCT01300156
What this trial is testing

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
National Cancer Center, Korea 37
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableStudy completedNCT02579551
What this trial is testing

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

Who this might be right for
Skin Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 179
Early research (Phase 1)Ended earlyNCT02641002
What this trial is testing

CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 28
Not applicableStudy completedNCT01173445
What this trial is testing

Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas 19
Not applicableUnknownNCT04172272
What this trial is testing

The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures

Who this might be right for
LeiomyomaPelvic Organ ProlapseAbnormal Uterine Bleeding+3 more
General Hospital Pula 75
Testing effectiveness (Phase 2)Study completedNCT03389295
What this trial is testing

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiayun He, MD 118
Not applicableLooking for participantsNCT07421739
What this trial is testing

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Who this might be right for
Choroidal MelanomaIndeterminate LesionsUveal Melanoma+1 more
Aura Biosciences 15
Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10
Testing effectiveness (Phase 2)Study completedNCT02844439
What this trial is testing

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Kadmon Corporation, LLC 40
Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Testing effectiveness (Phase 2)Ended earlyNCT02465957
What this trial is testing

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Who this might be right for
Stage IIIB Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma
ImmunityBio, Inc. 7
Post-approval studies (Phase 4)Study completedNCT03513757
What this trial is testing

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Who this might be right for
HeadacheTumorSeizure Disorder+4 more
Medical College of Wisconsin 40
Testing effectiveness (Phase 2)Study completedNCT03976401
What this trial is testing

Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 110
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Early research (Phase 1)Ended earlyNCT00030381
What this trial is testing

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT02689219
What this trial is testing

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Who this might be right for
Germ Cell TumorsTestis CancerTesticular Cancer+2 more
Nabil Adra 18
Testing effectiveness (Phase 2)Study completedNCT04835519
What this trial is testing

Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse LeukemiaRefractory Acute Myeloid Leukemia
Beijing Boren Hospital 5
Testing effectiveness (Phase 2)Study completedNCT00002619
What this trial is testing

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health 60
Load More Results